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Abstract 
BACKGROUND: Papua has a high cumulative number of HIV, which has expanded epidemic status with the 
most risk factors are heterosexuals.  
AIM: This study aims to determine factors associated with HIV disease progression include host and viral factors.  
METHODS: Eighty-four subjects recruited in Rumah Sakit Mitra Masyarakat (RSMM) VCT’s laboratory, 
interviewed with questionnaires and also did laboratory examinations. HIV-1 subtypes were identified using RT-
PCR, nested PCR and sequencing. Then, CD4+ data is checked using PIMA Analyzer. Demographic and clinical 
data obtained from the patient's medical record. After collected, data were analysed using Fisher's exact test.  
RESULTS: The results showed two factors that influence the progression of HIV disease were HIV subtypes (p = 
0.002) and Body Mass Index (p = 0.033). The HIV-1 subtype also correlated with CD4+ levels with a value of p = 
0.04.  
CONCLUSION: HIV-1 subtype correlates with HIV progression, so it is necessary to develop HIV/AIDS 
management strategies and clinical counselling. 
 
 
 
 
 
Introduction 
 
The report that provides by UNAIDS that the 
number of people living with HIV in the world reached 
34 million people with 17 million (50%) are women, 
and 2.1 million are children less than 15 years [1]. In 
June 2018, Papua recorded with the cases of HIV 
were 14.315 inhabitants and 2.114 people are dead 
because of AIDS. Heterosexuals are the highest risk 
factors of HIV transmission in Papua with 13.888 
cases, followed by mother to infant transmission by 
208 cases [2]. 
Generally, it needs eight to ten years for HIV 
to develop into AIDS. Several factors were found to 
contribute to the progression of HIV infection is a 
factor immunological, virological, environmental and 
genetic factors hosts [3], [4], [5], [6]. Factors that may 
affect the host is the Human Leukocyte Antigen 
(HLA), CYP polymorphisms, gender, age, ethnicity, 
psychosocial and body mass index (BMI). 
Environmental factors that affect the progression of 
diseases such as transmission modes and socio-
economic status [7]. Viral factors, including viral 
subtypes or mutations that destroy the virus [8]. 
A study in Thailand found that the subtypes of 
HIV-related manner and speed of transmission, where 
subtype B associated with the transmission of 
homosexuals and intravenous drug users (IDUs), 
while subtypes A, CRF01_AE, and C related to 
heterosexual transmission [9]. Studies conducted in 
Tanzania and Uganda found that subtype D correlated 
faster with a decrease in CD4
+
 T cells and increased 
disease progression than other subtypes and 
recombinant forms [10], [11]. However, a retrospective 
cohort study conducted during 1996 and 2007 reveals 
that Africans infected with subtype B has the 
progression of HIV/AIDS faster than those infected 
with non-B subtypes [12]. 
Many studies in other countries have reported 
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correlations between various factors with the 
progression of HIV disease, but in Indonesia, the data 
is still limited or limited.  
The purpose of this study is to determine what 
factors associated with the progression of HIV 
disease, including host factors, environmental and 
viral factors. 
 
 
Material and Methods 
 
Study and subject 
The study was conducted for ten months, 
from January to October 2015. Blood sampling was 
taken at the VCT Laboratory of Rumah Sakit Mitra 
Masyarakat (RSMM) Mimika. Samples are HIV/AIDS 
patients were selected for continuous sampling and 
has received antiretroviral therapy who have met the 
inclusion criteria. Calculation of sample size for cross-
sectional design uses the Lemeshow formula from the 
calculation results obtained eighty-four respondents. 
The results from interviews of demographic and 
clinical data with questionnaire collected for further 
processing. CD4
+
 examination uses the PIMA 
Analyzer and haematology examination using 
Sysmex. 
 
Subtyping HIV 
The extraction process uses a standard kit 
from Qiagen with catalogue # 52906. Firstly RT-PCR 
(Reverse Transcriptase-Polymerase Chain Reaction) 
amplification using a specific primer. The primers 
used are obtained from the HXB2 reference journal 
access code Geneva K03455 
(http://hiv.web.lanl.gov/NUM-HXB2.MAIN.html). 
Second is electrophoresis, and this stage aims to see 
the results of amplification in the previous step. The 
PCR results were detected by electrophoresis of 5 ul 
PCR products plus 1 ul loading buffer on 2% agarose 
gel and 100 v voltage for 40 minutes. The PCR 
product was visualised by placing the gel on the doc-
gel. DNA isolates which showed a band of 460 bp 
were affirmed to contain the target gene. The next 
stage is sequencing; Sequencing is done to find out 
the nucleotide sequence in several PCR gene 
envelope products. Sequencing using ABIPrism 3500 
Genetic Analyzer (Applied Biosystem, USA). This 
sequencing process is carried out in 2 stages, namely, 
cycle sequencing reaction and purification of PCR 
products and sequencing. Sequencing results were 
analysed using Bioedit software. The last is BLAST 
(Basic Local Alignment Search Tool) process, the 
purpose of which is to get the HIV genotype and 
subtype. BLAST was conducted using the internet to 
two gene bank sites to confirm; the two sites are 
BLAST from NCBI (National Center for Biotechnology 
Information) at www.ncbi.nlm.nih.gov and the HIV 
sequence database at www.hiv.lanl.gov. 
 
Statistical Analysis  
Statistical analysis was performed using 
Fisher's exact test for categorical variables. Briefly, a 
2 × 2 contingency table on the selected Data was 
constructed, and the two-tailed p-value. P values less 
than or equal to 0,05 were considered to be 
significant. 
 
 
Results  
 
Demographic Characteristics of Subjects 
Demographic characteristics showed that 
HIV/AIDS patients in Rumah Sakit Mitra Masyarakat 
(RSMM) Mimika dominated by women as many as 61 
people (72.6%), Papuans 60 people (71.4%), 
educated (81%), Working (83.3%), body mass index 
18.5-25 kg/m2 69 people (82.1%), married 47 people 
(56%), heterosexual transmission routes 80 people 
(95.2%), CD4
+
 levels as much as > 350 cells/mm
3
 77 
people (91.7%), and opportunistic infections of 
tuberculosis 69 people (82.1%). 
 
The factors associated with the 
 progression of HIV  
A significant relationship between 
demographic variables clinical and clinical stage of 
HIV/AIDS is a subtype variable, BMI and Route 
transmission. The results of the analysis are shown in 
Table 1. 
Table 1: Demographic Characteristic of study Subject 
Characteristic 
Clinical Stage (WHO) ∑ p 
I, II, III IV   
Sex 
Male 
Female 
 
17 
51 
 
6 
10 
 
23 
61 
 
0.356 
Ethnic 
Papua  
Non-papua 
 
50 
18 
 
10 
6 
 
60 
24 
 
0.375 
Subtype 
CRF01_AE 
Non-CRF01_AE 
 
30 
20 
 
8 
26 
 
38 
46 
 
0.002* 
Opportunistic Infection 
TB 
Non-TB 
 
56 
12 
 
13 
3 
 
69 
15 
 
1.000 
Body Mass Index 
Other 
Normally 
 
9 
59 
 
6 
10 
 
15 
69 
 
0.033* 
CD4
+ 
< 350 cell/mm3 
> 350 cell/mm3 
 
6 
62 
 
1 
15 
 
7 
77 
 
1.000 
Hemoglobin 
< 12 g/dl 
12-15 g/dl 
 
22 
28 
 
14 
20 
 
36 
48 
 
0.826 
Trombosit 
< 150.000 ul 
150 – 400.000 ul 
 
5 
45 
 
6 
28 
 
11 
73 
 
0.340 
CD4 Failure, < 50 
cell/mm3/year 
Yes 
No 
 
 
37 
31 
 
 
7 
9 
 
 
44 
40 
 
 
0.580 
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Table 2 shows the analysis of the relationship 
between the subtypes and clinical characteristics of 
the levels of CD4
+
 HIV patients in Mimika. Results 
indicated exhibited significantly between subtypes of 
HIV-1 and CD4
+
 cells of patients with p = 0:04 (α < 
0,05). The results of the analysis are shown in table 2. 
Table 2: The correlation between HIV-1 subtypes and the level 
of CD4 
Characteristic 
Cluster Differentiation-4 ∑ p 
< 350 > 350   
Sex 
Male 
Female 
 
2 
5 
 
21 
26 
 
23 
61 
 
0.62 
Ethnic 
Papua  
Non-papua 
 
6 
1 
 
54 
23 
 
60 
24 
 
0.66 
Subtype 
CRF01_AE 
Non-CRF01_AE 
 
6 
1 
 
33 
44 
 
39 
45 
 
0.04* 
Opportunistic Infection 
TB 
Non-TB 
 
7 
0 
 
62 
15 
 
69 
15 
 
0.34 
Transmission Mode 
Heterosexual 
Others 
 
7 
0 
 
73 
4 
 
80 
4 
0.70 
Body Mass Index 
Other 
Normally 
 
3 
4 
 
12 
65 
 
15 
69 
 
0.10 
Hemoglobin 
< 12 g/dl 
12-15 g/dl 
 
4 
3 
 
32 
45 
 
36 
48 
 
0.45 
 
 
 
Discussion 
 
Many factors affect the disease progression of 
HIV/AIDS, including host factors, environmental and 
viral factors [13]. Two factors that affect the 
progression in this study is a host factor is the body 
mass index and factor virus itself is a subtype of HIV-
1. One element that has a relationship with the clinical 
stage is the body mass index (BMI). BMI is one of the 
WHO's clinical assessment parameters that weight 
loss in people with HIV/AIDS. However, the 
association of BMI with CD4
+
 levels did not show 
significant results. In this study, the patients' BMI is 
normal for clinical stage I, II and III. A study in France 
showed that mortality was higher in patients with BMI 
between 16-18.4 kg/m
2
 with HR 2.2 (CI: 1.6-3.0) and a 
BMI < 16 is 4.4 (CI: 3.1-6.3) and standard BMI 18.5 
[14], [7]. These results are similar to studies in 
Surabaya which is one of the factors that affect the 
progression of HIV disease is the body mass index 
[7]. 
In addition to body mass index, HIV-1 subtype 
also has a significant relationship with clinical stage 
and CD4
+
. Correlation between HIV-1 subtypes and 
the development of the disease is controversial. 
Several studies have reported a correlation between 
subtypes of HIV-1 and the progression of HIV/AIDS by 
relating the time needed by HIV to develop AIDS, the 
rate of change low CD4
+
 counts, viral load high, and 
mortality associated with HIV/AIDS. CRF01_AE 
commonly identified in HIV/AIDS patients in Papua. 
This indicates that the recombinant form of the virus 
worldwide associated with faster disease progression, 
such as in Cuba and Brazil [15], [13]. 
This study shows that CRF01_AE associated 
with faster HIV/AIDS progression. Similarly, studies in 
China (Li, 2014; Ng, 2011). It found that CRF01_AE-
infected seroconversion experienced a faster rate of 
decline in CD4
+
 T cells, requiring earlier initiation of 
ART compared to non CRF01_AE patients [16]. 
The study held by Chu et al. reported that the 
level of low CD4
+
 changes was related to the 
CRF01_AE subtype [3]. Research in Indonesia in 
2013 reported that CRF01_AE subtype also has a 
higher prevalence than other subtypes and associated 
with the level of CD4
+
 cell changes in patients who 
had received HAART [17]. Subtype connection with 
deaths related to HIV/AIDS is still contradictory. 
Subtype CRF01_AE estimated time of the death of 
people with an average of 7.8 (7.0 to 9.1) years [18]. 
It remains unclear why CRF01_AE associated 
with CD4
+
 decline very quickly. However, several 
studies have shown that the high proportion of tropism 
X4 in the CRF01_AE subtype and also that X4 
tropism is associated with an increased rate of CD4
+
 
decline and progression for advanced 
immunosuppression [19], [20], [21]. Also, a decrease 
in the immune system on the host after infection with 
HIV-1 can allow the virus to grow and replicate 
independently. It can explain the increase in the rate 
of disease progression in HIV-infected patients with 
subtype CRF01_AE [22]. 
Some literature suggests that the virus 
subtype may affect the pathogenesis and progression 
of the disease during HIV infection. Hu, has reported 
that in PWID (people with an injected drug) patients 
with subtype CRF01_AE have higher plasma viral 
load compared to patients with subtype B, but there 
was no difference in the number of CD4
+
 T cells [23]. 
Recent research in Singapore reported a decline in 
CD4
+
 T cells faster for a shorter time in patients with 
subtype CRF01_AE than other subtypes [16]. 
Besides, in Shanghai, it was also reported that HIV 
homosexual patients with the CRF01_AE subtype 
found that more patients had lower initial CD4
+
 T cells. 
This subtype of HIV disease progression was faster to 
AIDS and CXCR4 tropism frequency greater than with 
other subtypes [24]. 
Direct comparison of HIV subtypes often 
complicated by uncertainty factors for instance: the 
way of transmission and timing of infection, host 
genetic diversity, effects of comorbid conditions, small 
sample size, identification methods that cannot 
distinguish between subtypes and recombinant 
strains. This analysis is limited to a relatively 
homogeneous population of incidences of cases with 
a clear infection time and a known mode of 
transmission (sexual exposure). 
It should be noted that despite the historical 
existence of subepidemics separated by genotypes 
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and risk factors, CRF01_AE now appears to be 
dominant in all risk groups throughout Asia [25]. It 
remains to be determined whether this can be 
accounted for by genetic DRIFT, or if there are 
inherent differences between strains such as plasma 
viral load, transmission or other biological or 
epidemiological factors that might underlie this shift. 
In conclusion, HIV-1 subtype CRF01_AE 
primarily associated with HIV disease progression, in 
this case, is a clinical-stage and CD4
+
. Routine 
surveillance of the subtypes of HIV-1 and CD4
+
 will be 
useful in monitoring the progression of HIV/AIDS and 
improving the management and clinical counselling. 
The further study combines subjects with different 
ethnic backgrounds, and functional evaluation can be 
used to examine the relationship between subtypes of 
HIV-1 and the progression of HIV/AIDS. The research 
may use more samples, and the factors involved 
include the use of viral load markers to monitor 
disease progression. Finally, the sequencing of the 
HIV genome as a whole is the ideal method for 
concluding the relationship of the subtype by 
conducting a co-receptor analysis. 
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